Logo.png
Vyant Bio Provides Update on Winddown Activities
26. Dezember 2023 09:15 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its...
Logo.png
Vyant Bio Provides Update on Winddown Activities
10. November 2023 16:05 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its...
Logo.png
Vyant Bio Announces Stockholder Approval of Plan of Dissolution
01. November 2023 11:45 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is announcing the results of its special meeting of stockholders on November 1, 2023 (the...
Logo.png
Vyant Bio Announces Completion of StemoniX Asset Sale
24. Oktober 2023 16:00 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) announced that it has completed the sale of all or substantially all of the assets of the...
Logo.png
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
28. September 2023 11:45 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of stockholders on September 28, 2023 (the...
Logo.png
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
20. September 2023 13:00 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of stockholders on September 20, 2023 (the...